Nanomaterial research potential “game-changer” for drug delivery
By Catherine Eckford (European Pharmaceutical Review)
European Commission approves Rytelo for LR- MDS-related anaemia
By European Pharmaceutical Review
MSD bolsters US manufacturing capacity with $1b investment
By Catherine Eckford (European Pharmaceutical Review)
Bristol Myers Squibb to acquire 2seventy bio
By Catherine Eckford (European Pharmaceutical Review)
Preparing for a new era in the rare disease sector
By Catherine Eckford (European Pharmaceutical Review), Christina Gkousgkouni (Sanofi)
Harnessing industry advancements to accelerate upstream process development
By Dr Li Yang (Altruist Biologics), Dr Shidong Shi (Altruist…